| Benjamin Arthur Kooiker, DO | |
|
2450 Riverside Ave, Minneapolis, MN 55454 | |
| (612) 672-6000 | |
| Not Available |
| Full Name | Benjamin Arthur Kooiker |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 15 Years |
| Location | 2450 Riverside Ave, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053548933 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | DO-4437 (Iowa) | Secondary |
| 207P00000X | Emergency Medicine | 63384 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Minnesota Medical Center, Fairview | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairview Health Services | 1951213057 | 559 |
News Archive
In the face of an emerging liver cancer crisis in Asia, researchers at the Chinese University of Hong Kong have developed a test that could help millions.
A RAND Corporation study issued today says school playgrounds and athletic facilities can be important tools in the fight against childhood obesity, but many are locked and inaccessible to children on weekends - especially in poor and minority neighborhoods.
The New York Times reports that these problem areas include rejection of claims for medical services and limits on prescription drug coverage. News outlets also report on ACOs grades and Medicare Advantage rate shifts.
Bayer HealthCare and Onyx Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted priority review designation to Bayer HealthCare's New Drug Application (NDA) filed end of April 2012 for the oral multi-kinase inhibitor regorafenib, for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
› Verified 9 days ago
| Entity Name | Fairview Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
In the face of an emerging liver cancer crisis in Asia, researchers at the Chinese University of Hong Kong have developed a test that could help millions.
A RAND Corporation study issued today says school playgrounds and athletic facilities can be important tools in the fight against childhood obesity, but many are locked and inaccessible to children on weekends - especially in poor and minority neighborhoods.
The New York Times reports that these problem areas include rejection of claims for medical services and limits on prescription drug coverage. News outlets also report on ACOs grades and Medicare Advantage rate shifts.
Bayer HealthCare and Onyx Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted priority review designation to Bayer HealthCare's New Drug Application (NDA) filed end of April 2012 for the oral multi-kinase inhibitor regorafenib, for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Benjamin Arthur Kooiker, DO 1227 E Rusholme St, Davenport, IA 52803-2459 Ph: (563) 421-1000 | Benjamin Arthur Kooiker, DO 2450 Riverside Ave, Minneapolis, MN 55454 Ph: (612) 672-6000 |
News Archive
In the face of an emerging liver cancer crisis in Asia, researchers at the Chinese University of Hong Kong have developed a test that could help millions.
A RAND Corporation study issued today says school playgrounds and athletic facilities can be important tools in the fight against childhood obesity, but many are locked and inaccessible to children on weekends - especially in poor and minority neighborhoods.
The New York Times reports that these problem areas include rejection of claims for medical services and limits on prescription drug coverage. News outlets also report on ACOs grades and Medicare Advantage rate shifts.
Bayer HealthCare and Onyx Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted priority review designation to Bayer HealthCare's New Drug Application (NDA) filed end of April 2012 for the oral multi-kinase inhibitor regorafenib, for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
› Verified 9 days ago
Daniel Hart, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 701 Park Ave, Minneapolis, MN 55415 Phone: 612-873-3000 | |
Mr. Collin Markham Cousins, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 E 28th St # Mr 11112, Minneapolis, MN 55407 Phone: 612-863-4233 | |
Brenda Leech, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 E 28th St, Minneapolis, MN 55407 Phone: 612-863-3547 | |
Paul C Allegra, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Park Ave, Minneapolis, MN 55415 Phone: 612-873-3000 | |
Dr. Kurt Andrew Hessen, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 701 Park Ave, Minneapolis, MN 55415 Phone: 612-873-3000 | |
Dr. Bar Ferents, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 701 Park Ave, Minneapolis, MN 55415 Phone: 612-873-3000 | |
Margot Samson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 701 Park Ave, Minneapolis, MN 55415 Phone: 612-873-5683 |